AGP Executive Report
Last update: 7 hours agoDigital Identity: youniqx Identity opened a public testing platform for its European digital identity wallet, inviting developers to try cross-border services. Healthcare: The EU approved Revolution Medicines’ pancreatic cancer drug Rasonque for the EEA, including Liechtenstein; patient access will depend on local pricing and reimbursement. Event Technology: Swiss firm menzi ebz will distribute and support Follow-Me’s performer-tracking systems in Liechtenstein and Switzerland. Trade: The Vietnam-EFTA deal, which includes Liechtenstein, could remove tariffs on more than 90% of goods, but exporters must meet strict origin, quality and sustainability rules; ratification is still required. Banking: A survey of Swiss and Liechtenstein banks found 65% expect to keep their core banking systems for another decade, despite concerns about usability and slow innovation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.